Reaction Details Report a problem with these data
Target
Aurora kinase B
Ligand
BDBM413459
Substrate
n/a
Meas. Tech.
Enzyme Assay
IC50
<10000±n/a nM
Citation
 Finlay, MR; Goldberg, FW; Ting, AK Amino-triazolopyridine compounds and their use in treating cancer US Patent  US10407446 Publication Date 9/10/2019 
Target
Name:
Aurora kinase B
Synonyms:
AIK2 | AIM-1 | AIM1 | AIRK2 | ARK2 | AURKB | AURKB_HUMAN | Aurora B kinase (aurB) | Aurora B-INCENP | Aurora kinase 2 | Aurora kinase B (AURKB) | Aurora-related kinase 2 | STK-1 | STK1 | STK12 | STK5 | Serine/threonine-protein kinase aurora B
Type:
Protein
Mol. Mass.:
39327.72
Organism:
Homo sapiens (Human)
Description:
Q96GD4
Residue:
344
Sequence:
MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMENSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPMGAQDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA
  
Inhibitor
Name:
BDBM413459
Synonyms:
9-((1s,4s)-4-hydroxy-1-methylcyclohexyl)-7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-7,9-dihydro-8H-purin-8-one | US10407446, Example 12 | US11136340, Example 12
Type:
Small organic molecule
Emp. Form.:
C20H24N8O2
Mol. Mass.:
408.457
SMILES:
Cc1cc2ncnn2cc1Nc1ncc2n(C)c(=O)n(c2n1)[C@]1(C)CC[C@H](O)CC1 |r,wU:26.30,wD:22.26,(3.41,-5.24,;3.41,-3.7,;4.74,-2.93,;4.74,-1.39,;5.89,-.36,;5.26,1.05,;3.73,.89,;3.41,-.62,;2.08,-1.39,;2.08,-2.93,;.74,-3.7,;-.59,-2.93,;-1.92,-3.7,;-3.26,-2.93,;-3.26,-1.39,;-4.4,-.36,;-5.89,-.76,;-3.78,1.05,;-4.17,2.53,;-2.24,.89,;-1.92,-.62,;-.59,-1.39,;-1.15,1.97,;-2.64,2.37,;.33,1.58,;1.42,2.66,;1.02,4.15,;2.11,5.24,;-.46,4.55,;-1.55,3.46,)|
Structure:
Search PDB for entries with ligand similarity: